NFG protects international patients from aggressive hospital debt collectors by enforcing FDCPA laws and issuing Cease & Desist letters to stop harassment.
The NFG team outlines key cost factors this quarter including tariffs, regulation, and market pressure and reviews their impacts on the international inbound to US market.
New Frontier Group managed a US clinical trial case, saving 47.63% on costs while ensuring patient care and insurer reputation. Their approach balanced arbitration, oversight, and family support for a successful outcome in global medical travel.